Literature DB >> 19434335

Liver transplantation in Asia: past, present and future.

Kelvin K Ng1, Chung Mau Lo.   

Abstract

With the technical advances and improvements in perioperative management and immunosuppressants, liver transplantation is the standard treatment for patients with end-stage liver diseases. In Asia, a shortage of deceased donor liver grafts is the universal problem to be faced with in all transplant centres. Many surgical innovations are then driven to counteract this problem. This review focuses on 3 issues that denote the development of liver transplantation in Asian countries. These include living donor liver transplantation (LDLT), split liver transplantation (SLT) and liver transplantation for hepatocellular carcinoma (HCC). Minimal graft weight, types of liver graft to donate and the inclusion of the middle hepatic vein with the graft are the main issues to be established in LDLT. The rapid growth and wide dissemination of LDLT has certainly alleviated the supply-and-demand problem of liver grafts in Asia. SLT is another attractive approach. Technical expertise, donor selection and graft allocation are the main determinants for its success. Liver transplantation plays a key role in the management of HCC in Asia. LDLT would be the main strategy in this aspect. The issue of extending the selection criteria for HCC patients for LDLT is still controversial. On the whole, future developments to increase the donor pool for the expanding recipient need in Asia would involve transplantation from non-heart beating donor and ABO incompatible transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19434335

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  10 in total

1.  Metabolic syndrome after a liver transplantation in an Asian population.

Authors:  Hwee Leong Tan; Kieron B L Lim; Shridhar Ganpathi Iyer; Stephen K Y Chang; Krishnakumar Madhavan; Alfred W C Kow
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

Review 2.  Living Donor Liver Transplantation for Hepatocellular Carcinoma: An Asian Perspective.

Authors:  Young-In Yoon; Sung-Gyu Lee
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

3.  Reversal of severe hepatopulmonary syndrome in chronic hepatic cirrhosis by living donor liver transplantation: report of two cases.

Authors:  Kefei Chen; Bo Li
Journal:  Surg Today       Date:  2011-03-02       Impact factor: 2.549

4.  Cost and efficacy of immunosuppression using generic products following living donor liver transplantation in India.

Authors:  S Sudhindran; Shameena Aboobacker; Ramachanndran N Menon; G Unnikrishnan; O V Sudheer; Puneet Dhar
Journal:  Indian J Gastroenterol       Date:  2011-12-23

5.  Effects of donor steatosis on liver biochemistry and significance of body mass index in predicting steatosis.

Authors:  Rohan C Siriwardana; See Ching Chan; Kenneth S H Chok; Chung Mau Lo; Sheung Tat Fan
Journal:  HPB (Oxford)       Date:  2012-05-29       Impact factor: 3.647

6.  Why does living donor liver transplantation flourish in Asia?

Authors:  Chao-Long Chen; Catherine S Kabiling; Allan M Concejero
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-10-08       Impact factor: 46.802

Review 7.  Biliary strictures complicating living donor liver transplantation: Problems, novel insights and solutions.

Authors:  Harshavardhan B Rao; Arjun Prakash; Surendran Sudhindran; Rama P Venu
Journal:  World J Gastroenterol       Date:  2018-05-21       Impact factor: 5.742

Review 8.  Decision modelling for economic evaluation of liver transplantation.

Authors:  Zhi Qu; Christian Krauth; Volker Eric Amelung; Alexander Kaltenborn; Jill Gwiasda; Lena Harries; Jan Beneke; Harald Schrem; Sebastian Liersch
Journal:  World J Hepatol       Date:  2018-11-27

9.  Severe polycystic liver diseases: hepatectomy or waiting for liver transplantation?: Two case reports.

Authors:  Zeyu Zhang; Kuan Hu; Jiajin Yang; Yufan Zhou; Zhiming Wang; Yun Huang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

10.  Deficiency in Inactive Rhomboid Protein2 (iRhom2) Alleviates Alcoholic Liver Fibrosis by Suppressing Inflammation and Oxidative Stress.

Authors:  Yangwenshu Liu; Qin Kuang; Xianling Dai; Minxia Zhan; Li Zhou; Liancai Zhu; Bochu Wang
Journal:  Int J Mol Sci       Date:  2022-07-12       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.